COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 6 FDA records to the applicant name Impulse Dynamics (Usa), Inc.. It includes 1 original PMA approval. 3 entries are PMA supplements. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 21, 2019 to Oct 14, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QFV appears in 6 of the 6 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P180036, with 6 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 3 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 50 Lake Center Executive Pkwy., 401 Rte. 73 N, Bldg. 50 Suite 100, Marlton, NJ, 08053. Recorded on P180036/S046, decision dated Oct 14, 2026.
Device categories in this collection
Implantable Pulse Generator.
Changes described in PMA records
FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-14 for P180036/S046, a supplement to the OPTIMIZER Smart and Smart Mini System under applicant Impulse Dynamics (Usa), Inc. The listed supplement reason is a process change involving manufacturer, sterilizer, packager or supplier, and the recorded statement identifies an additional ethylene oxide (EO) sterilizer. The device category is implantable pulse generator, specialty cardiovascular, product code QFV.
This entry documents a manufacturing-process change within the existing P180036 file rather than a new approval of the whole system. The notice does not state which sterilizer facility was added, whether it replaces or supplements existing capacity, or any conditions of the decision. No supporting documents were included in the source record, so the scope of the change and any effect on the cleared system cannot be assessed from this data alone.
The record does not describe clinical, labeling or patient-selection implications, and none should be inferred from the notice.
FDA approval-order wording
an additional ethylene oxide (EO) sterilizer
Oct 14, 2026 · 30-Day NoticeThe FDA recorded an approval decision on 2026-09-24 for P180036/S044, a PMA supplement to the OPTIMIZER Smart System from Impulse Dynamics (Usa), Inc. The supplement is classified as a Real-Time Process submission with a stated reason of Change Design/Components/Specifications/Material, and the recorded statement describes implementing a new fuse with improved suitability.
This action concerns a component-level change to an implantable pulse generator in the cardiovascular specialty under product code QFV; it is not an approval of the entire system. The source record does not identify the fuse's specifications, the affected device model or the verification performed, and no supporting documents were supplied, so the technical basis for the decision cannot be assessed from this data alone.
FDA approval-order wording
approval for implementing a new fuse with improved suitability
Sep 24, 2026 · Real-Time ProcessFDA’s recorded scope: an alternative vapor degreasing solvent used by a supplier
May 13, 2026 · 30-Day NoticeFDA’s recorded scope: Approval for design changes to the GUARDIO/VESTA Charger power supply connector.
Apr 10, 2026 · Real-Time ProcessFDA’s recorded scope: a process change for epoxy headers of OPTIMIZER implantable pulse generators
Nov 19, 2025 · 135 Review Track For 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.